Detail of "132-93-4"
- CAS Number:
- 132-93-4
- Name:
4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid, 3,3-dimethyl-7-oxo-6-[(1-oxo-2-phenoxypropyl)amino]-, potassium salt(1:1)
- Molecular Structure:
![Molecular Structure of 132-93-4 (4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid, 3,3-dimethyl-7-oxo-6-[(1-oxo-2-phenoxypropyl)amino]-, potassium salt(1:1))](http://www.lookchem.com/300w/2010/0618/132-93-4.jpg)
- Formula:
- C17H20 N2 O5 S . K
- Molecular Weight:
- 402.54
- Synonyms:
- 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid, 3,3-dimethyl-7-oxo-6-(2-phenoxypropionamido)-, monopotassium salt(7CI,8CI); 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid,3,3-dimethyl-7-oxo-6-[(1-oxo-2-phenoxypropyl)amino]-, monopotassium salt,(2S,5R,6R)- (9CI); 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid,3,3-dimethyl-7-oxo-6-[(1-oxo-2-phenoxypropyl)amino]-, monopotassium salt,[2S-(2a,5a,6b)]-; Alfacillin; Astracillin; BRL 152; Bendralan; Brocsil; Broxil;Chemipen; Chemipen C; Darcil; Dramcillin S; Maxipen; Oralopen; Pen 200; Pensig;Phenethicillin K salt; Phenethicillin potassium; Phenethicillin potassium salt;Pheneticillin potassium; Pheno-M-penicillin; Phenoxyethylpenicillin potassium;Potassium (1-phenoxyethyl)penicillin; Potassium (a-phenoxyethyl)penicillin; Potassium 6-(a-phenoxypropionamido)penicillanate;Potassium methylphenoxymethylpenicillin; Potassium phenethicillin; Potassiumphenoxyethylpenicillin; Priospen; Ro-Cillin; Semopen; Synapen; Syncillin;Synerpenin; Synthecillin; Synthecilline; a-Oracillin; a-Phenoxyethylpenicillin potassium; a-Phenoxyethylpenicillin potassiumsalt
- Safety:
- Poison by intravenous route. Moderately toxic by intraperitoneal route. When heated to decomposition it emits toxic fumes of K2O, SOx, and NOx. Details
4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid, 3,3-dimethyl-7-oxo-6-[(1-oxo-2-phenoxypropyl)amino]-, potassium salt(1:1)
![Molecular Structure of 132-93-4 (4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid, 3,3-dimethyl-7-oxo-6-[(1-oxo-2-phenoxypropyl)amino]-, potassium salt(1:1))](http://www.lookchem.com/300w/2010/0618/132-93-4.jpg)
Famous Chemical Enterprises
-
Livzon -
Total -
Shell -
Dupont -
Exxonmobil -
Akzonobel -
Basf -
Bayer -
BP
Please post your buying leads,so that our qualified suppliers
will soon contact you!
*Required Fields
Reference
- Light scattering studies on micelle formation by some penicillins in aqueous solutions
- Light scattering studies on micelle formation by some penicillins in aqueous solutions. Attwood, D.; Agarwal, S. P. (Pharm. Dep., Univ. Manchester, Manchester M13 9PL, UK). J. Pharm. Pharmacol., 36(8), 563-4 (English) 1984. CODEN: JPPMAB. ISSN: 0022-3573. DOCUMENT TYPE: Journal CA Section: 63 (Pharmaceuticals) The aggregation of a no. of penicillins, both in water and in electrolyte soln., was examd. by total intensity light scattering methods. Micellar assocn. was noted for Na carfecillin [21649-57-0], Na flucloxacillin [1847-24-1], cloxacillin [61-72-3], phenethicillin potassium salt [132-93-4] and penicillin V potassium salt [132-98-9] and crit. micelle concns. and micellar aggregation nos. were detd. Assocn. of penicillin G potassium salt [113-98-4] in water and electrolyte was limited to dimer and trimer formation.
- Comparative pharmacodynamics and clinical pharmacokinetics of phenoxymethylpenicillin and pheneticillin
- Comparative pharmacodynamics and clinical pharmacokinetics of phenoxymethylpenicillin and pheneticillin. Overbosch, D.; Mattie, H.; Van Furth, R. (Dep. Infect. Dis., Univ. Hosp., Leiden 2333 AA, Neth.). Br. J. Clin. Pharmacol., 19(5), 657-68 (English) 1985. CODEN: BCPHBM. ISSN: 0306-5251. DOCUMENT TYPE: Journal CA Section: 1 (Pharmacology) Section cross-reference(s): 10 The antimicrobial effects of phenoxymethylpenicillin (PM) [87-08-1] and pheneticillin (PE) [147-55-7] in vitro and in an exptl. animal infection model were compared; pharmacokinetics of both the drugs were also studied in patients. For the inhibitory effect of PM on short-term (3 h) growth of Staphylococcus aureus in vitro, this drug was 2.13 times more potent than PE. The protein binding of both drugs was similar (78-80%). The potency ratio of PM to PE against S. aureus in an exptl. mouse-thigh infection was only 1.25 to 1. This is explained by the difference in the area under the curve after s.c. administration of PM (0.47 mg/L h) and PE (0.92 mg/L h). The plasma clearance after i.v. administration of PM was 476.4 mL/min and that of PE was 295.1 mL/min; the plasma clearance of both drugs was strongly correlated with the creatinine clearance. The vol. of distribution in the steady state of PM was 35.4 L and that of PE 22.5 L. In 10 patients, the absorption after oral administration of PM as the acid was 48% and that of the K salt of PE [132-93-4] was 86% of the dose. Thus, a difference in effectiveness of different formulations of PM and PE would depend entirely on differences in absorption.

